Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 242
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07053891 LUPKYNIS Drug-use Results Survey |
Voclosporin (LUPKYNIS) | Lupus | À vérifier | RECRUITING | En attente / non publié | Otsuka Pharmaceutical Co., Ltd. | Japan · Pharmacovigilance Department, Osaka, Japan | 2025-09-17 → 2032-06-30 | Ouvrir |
| NCT07123519 A Clinical Study of YTS109 Cells for the Treatment of R/R Autoimmune Di… |
YTS109 cell | Lupus | Phase 1 | RECRUITING | En attente / non publié | China Immunotech (Beijing) Biotec… | China · Institute of Hematology & Blood Diseases Hosp… | 2025-08-13 → 2027-08-13 | Ouvrir |
| NCT06978647 A Clinical Study of YTS109 Cell in R/R Autoimmune Diseases |
YTS109 cell | Lupus | Phase 1 | RECRUITING | En attente / non publié | China Immunotech (Beijing) Biotec… | China · The First Medical Center of Chinese PLA Gener… | 2025-05-19 → 2027-05-19 | Ouvrir |
| NCT07104721 A Clinical Study of YTS109 Cell for R/R Autoimmune Diseases |
YTS109 cell | Lupus | Phase 1 | RECRUITING | En attente / non publié | China Immunotech (Beijing) Biotec… | China · The First Affiliated Hospital of Anhui Medica… | 2025-08-04 → 2028-12-30 | Ouvrir |
| NCT07778446 A Study to Test CRT-402 in Refractory Autoimmune Disease |
CRT-402 | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | Myeloid Therapeutics | Australia · Linear Advanced Clinical Trial Centre, Gr… | 2026-08-26 → 2029-08-01 | Ouvrir |
| NCT06647069 A Study to Evaluate the Safety and Activity of SAR448501/DR-0201 in Pat… |
SAR448501 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Sanofi | Australia, Bosnia and Herzegovina, Georgia, New Zeala… | 2025-03-27 → 2029-06-25 | Ouvrir |
| NCT07598396 SOLUNA — A Study to Evaluate Mosunetuzumab in Participants With Systemi… |
Mosunetuzumab | Lupus | Phase 2 | RECRUITING | En attente / non publié | Hoffmann-La Roche | Argentina, Brazil, Colombia, Italy, Mexico, South Afr… | 2026-05-25 → 2028-08-31 | Ouvrir |
| NCT06613360 A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell … |
CLN-978 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Cullinan Therapeutics Inc. | United States, Australia, Bulgaria, France, Georgia, … | 2025-01-21 → 2027-12 | Ouvrir |
| NCT07729826 C-CAR168, an Autologous Anti-CD20/BCMA Chimeric Antigen Receptor T-Cell… |
C-CAR168 | SEP | Phase 2 | NOT_YET_RECRUITING | En attente / non publié | Huashan Hospital | Non communiqué | 2026-09-30 → 2029-09-01 | Ouvrir |
| NCT07873931 A Study of BMS-986553 in Participants With Refractory Autoimmune Diseas… |
BMS-986553 | Maladie rénale chronique | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States, Belgium, France, Germany, Netherlands,… | 2026-10-30 → 2033-01-31 | Ouvrir |
| NCT06653556 A Study of LCAR-AIO in Subjects With Relapsed/Refractory Systemic Lupus… |
LCAR-AIO T cells | Lupus | Phase 1 | COMPLETED | En attente / non publié | Union Hospital, Tongji Medical Co… | China · Wuhan Union Hospital, Wuhan, China | 2025-01-08 → 2026-06-06 | Ouvrir |
| NCT06943937 A Clinical Study of YTS109 Cell in R/R Systemic Lupus Erythematosus |
YTS109 cell injection | Lupus | Phase 1 | TERMINATED | En attente / non publié | China Immunotech (Beijing) Biotec… | China · Beijing GoBroad Hospital, Beijing, China | 2025-04-16 → 2026-04-25 | Ouvrir |
| NCT06293365 Two-period Crossover Study to Demonstrate the Comparability of Pharmaco… |
VAY736 1ml PFS | Lupus | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Canada, Czechia, Hungary, I… | 2024-07-02 → 2029-01-16 | Ouvrir |
| NCT07361094 Autologous CD19/BCMA Dual-Target CAR-T for Relapsed/Refractory Autoimmu… |
Autologous CD19-BCMA Dual-Target … | Lupus | Phase 1 | WITHDRAWN | En attente / non publié | Beijing Boren Hospital | China · Beijing GoBroad Boren Hospital, Beijing, China | 2025-11-06 → 2028-06 | Ouvrir |
| NCT05798117 An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics o… |
YTB323 | Lupus | Phase 1/2 | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | Australia, France, Germany, Spain, Switzerland · Nova… | 2023-02-28 → 2026-09-24 | Ouvrir |
| NCT05126277 SIRIUS-LN — Safety, Efficacy and Tolerability of Ianalumab Versus Place… |
ianalumab s.c. q4w | Lupus | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Brazil, Canada, Chile, Chin… | 2022-07-14 → 2031-02-04 | Ouvrir |
| NCT05268289 Study of Efficacy and Safety of LNP023 in Participants With Active Lupu… |
Iptacopan (part 1) | Lupus | Phase 2 | TERMINATED | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Brazil, China, Colombia, Fr… | 2022-08-10 → 2026-10-01 | Ouvrir |
| NCT05765006 CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Eryth… |
Relma-cel | SEP | Phase 1 | UNKNOWN | En attente / non publié | Shanghai Ming Ju Biotechnology Co… | China · Relma-cel Medical, Shanghai, China | 2023-02-24 → 2025-12-30 | Ouvrir |
| NCT07331467 Study of Ultra-Fast CD19 CAR-T Therapy for Refractory SLE |
CD19 CAR-T cells | SEP | Phase 1 | RECRUITING | En attente / non publié | Chongqing Precision Biotech Co., … | China · Affiliated Drum Tower Hospital, Medical Schoo… | 2026-01 → 2028-08 | Ouvrir |
| NCT05352919 EMERALD — A Study to Learn More About the Long-Term Safety of Litifilim… |
Litifilimab | Lupus | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | Biogen | United States, Argentina, Belgium, Brazil, Bulgaria, … | 2022-06-10 → 2032-05-03 | Ouvrir |
| NCT06434363 Phase I/II Study of AD-PluReceptor Plus Tafasitamab-cxix and Lymphodepl… |
Tafasitamab | Lupus | Phase 1/2 | RECRUITING | En attente / non publié | M.D. Anderson Cancer Center | United States · MD Anderson Cancer Center, Houston, U… | 2024-07-31 → 2030-12-31 | Ouvrir |
| NCT07104344 Study of CM355 in Patients With Systemic Lupus Erythematosus |
CM355 | Lupus | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Second Xiangya Hospital of Centra… | China · Second Xiangya Hospital of Central South Univ… | 2025-09-25 → 2027-09-01 | Ouvrir |
| NCT04868838 Daratumumab to Treat Active Lupus Nephritis |
Daratumumab | Lupus | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | Mayo Clinic | United States · Mayo Clinic in Rochester, Rochester, … | 2021-04-20 → 2027-01 | Ouvrir |
| NCT03747159 SynBioSe-2 — Synergetic B-cell Immunomodulation in SLE - 2nd Study. |
Belimumab Injection | Lupus | Phase 3 | COMPLETED | En attente / non publié | Leiden University Medical Center | Netherlands · HagaZiekenhuis, The Hague, Netherlands … | 2018-10-01 → 2026-06-22 | Ouvrir |
| NCT07276958 A Study of LY4298445 in Healthy Participants and Participants With Syst… |
LY4298445 | Lupus | Phase 1 | RECRUITING | En attente / non publié | Eli Lilly and Company | Australia, China, Japan · Anhui Provincial Hospital, … | 2026-02-04 → 2028-03 | Ouvrir |